Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
AqueSys, Inc. has 2 pending office actions in Medical Devices & Mechanical Engineering. The matters involve 2 distinct examiners but 1 distinct art unit. WIEST, PHILIP R is the busiest examiner, with 1 pending action.
The common art-unit classification creates an opportunity to compare claim construction and prior-art treatment across the two matters, even though the examiners differ. Counsel should use that shared technical context for consistency checks while preparing separate responses. The WIEST matter represents one examiner path, and the data does not identify a repeated examiner assignment.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WIEST, PHILIP R | 1 | 81.5% | +16.1% |
| WENG, KAI H | 1 | 70.0% | +17.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18894589 | INTRAOCULAR DRUG DELIVERY | WIEST, PHILIP R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18894589 | INTRAOCULAR DRUG DELIVERY | WIEST, PHILIP R | — |
| 18807036 | INTRAOCULAR SHUNT IMPLANTATION METHODS AND DEVICES | WENG, KAI H | — |
| Art Unit | Apps |
|---|---|
| 3781 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18894589 | INTRAOCULAR DRUG DELIVERY | WIEST, PHILIP R | 3781 | DP | Final Rejection | — | Pending | Sep 24, 2024 |
| 18807036 | INTRAOCULAR SHUNT IMPLANTATION METHODS AND DEVICES | WENG, KAI H | 3781 | DP | Non-Final OA | — | Pending | Aug 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAqueSys, Inc. has 2 pending office actions as of October 2026, spread across 1 art units and 2 examiners.
Philip R Wiest has the most, with 1 of AqueSys, Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
